Dec. 13, 2024 — A recent study by the Harvey L. Neiman Health Policy Institute demonstrates that mobile mammography is generally used by women otherwise unlikely to be screened, and thus is complementary to facility-based mammography rather than a substitute for it. Hence, mobile mammography could feasibly increase breast cancer screening rates, especially in traditionally underserved communities.

Dec. 18, 2024 – Accuray Inc. recently announced an international retrospective multicenter analysis found that radiosurgery (SRS) and fractionated stereotactic radiotherapy (FSRT), delivered with the CyberKnife System, can provide an effective and time-saving treatment option for brainstem metastases (BSM). The nine institution study results, published in the International Journal of Cancer, “underscore the long- term benefits in local control and the robust safety profile despite the delicate location of the treated metastases.1”

Dec. 12, 2024 — RIVANNA  has released a report that details significant regional demand for anesthesiologists while also examining the rapid growth of the diagnostic ultrasound market, a development influenced by technological advancements and evolving healthcare needs.

Dec. 12, 2024 — At RSNA 2024, Careverse officially made its debut, exhibiting in the AI Showcase area, sharing its innovative achievements in multimodal imaging AI and large language models with medical experts and scientists from around the world.

Careverse is committed to empowering a new era of smart healthcare by creating an AI-powered Digital Doctor which assists human doctors to deliver much more efficient, accurate, consistent and accessible patient care.

Dec. 17, 2024 — Radin Health, a provider of advanced radiology AI-Powered solutions, highlighted its All-in-One Radiology Workflow Management Solution at RSNA '24 in Chicago, IL.

Dec. 12, 2024 — The American Registry of Radiologic Technologists (ARRT) applauds Senators John Boozman (R-AR) and Ben Ray Lujan (D-NM) for introducing the Medicare Access to Radiology Care Act of 2024 (MARCA).

Dec. 3, 2024 — During RSNA '24, GE HealthCare announced the 510(k) submission to the U.S. Food and Drug Administration for CleaRecon DL, deep learning technology, designed to improve the quality of cone-beam computed tomography (CBCT) images by bringing artificial intelligence (AI)-based 3D reconstruction to the interventional suite.  

Dec. 4, 2024 - EDAP TMS SA, a leader in robotic energy-based therapies, recently announced the publication of the full results from the HIFI study in the peer-reviewed journal, European Urology. The study evaluated HIFU versus radical prostatectomy (RP) as a first line treatment of localized prostate cancer. The paper, “Whole-gland or Subtotal High-intensity Focused Ultrasound Versus Radical Prostatectomy: The Prospective, Noninferiority, Nonrandomized, HIFI Trial,” is authored by Dr. Guillaume Ploussard from Department of Urology, UROSUD, Clinique La Croix du Sud, France.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now